Impact of residential medication management reviews on drug burden index in aged-care homes: A retrospective analysis

Drugs and Aging

Volumn 26, Issue 8, 2009, Pages 677-686

  Nishtala, Prasad S ^a   Hilmer, Sarah N ^b,c   McLachlan, Andrew J ^a,d   Hannan, Paul J ^e   Chen, Timothy F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c University of Sydney   (Australia)

^d Department of Microbiology and Infectious Diseases   (Australia)

^e Meditrax Pharmacy   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; SEDATIVE AGENT;

AGED; ARTICLE; DRUG BURDEN IINDEX; DRUG DOSE REGIMEN; FEMALE; GENERAL PRACTITIONER; GERIATRIC CARE; HOME FOR THE AGED; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; DRUG PRESCRIPTIONS; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; PHARMACEUTICAL SERVICES; PHYSICIANS, FAMILY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 69049115213     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11316440-000000000-00000     Document Type: Article

References (41)

1. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56 (2): 163-184
2. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007; 21 (3): 217-230
3. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009; 85 (1): 86-88
4. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancertreatment trials. N Engl J Med 1999; 341 (27): 2061-2067 (Pubitemid 30035956)
5. Wenger NK. Enrollment and maintenance of elderly patients in cardiovascular clinical trials. Am J Geriatr Cardiol 2006; 15 (6): 352-356
6. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163 (22): 2716-2724
7. Basger BJ, Chen TF, Moles RJ. Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging 2008; 25 (9): 777-793
8. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294 (6): 716-724 (Pubitemid 41159291)
9. Guralnik JM, Ferrucci L, Simonsick EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995; 332 (9): 556-561
10. Terry DF, Sebastiani P, Andersen SL, et al. Disentangling the roles of disability and morbidity in survival to exceptional old age. Arch Intern Med 2008; 168 (3): 277-283 (Pubitemid 351281673)
11. Gray SL, LaCroix AZ, Hanlon JT, et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 2006; 54 (2): 224-230
12. Mulsant BH, Pollock BG, Kirshner M, et al. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 2003; 60 (2): 198-203 (Pubitemid 36173127)
13. Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007; 167 (8): 781-787
14. Iyer S, Naganathan V, McLachlan AJ, et al. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008; 25 (12): 1021-1031
15. Landi F, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 2007; 81 (2): 235-241 (Pubitemid 46174821)
16. Cao YJ, Mager DE, Simonsick EM, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther 2008; 83 (3): 422-429
17. Gnjidic D, Cumming RG, Le Couteur DG, et al. Drug burden index and physical function in older Australian men. Br J Clin Pharmacol 2009 Jul; 68 (1): 97-105
18. Rosano C, Simonsick EM, Harris TB, et al. Association between physical and cognitive function in healthy elderly: the Health, Aging and Body Composition study. Neuroepidemiology 2005; 24 (1-2): 8-14
19. Campbell AJ, Robertson MC, Gardner MM, et al. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999; 47 (7): 850-853
20. van der Velde N, Stricker BH, Pols HA, et al. Withdrawal of fall-risk-increasing drugs in older persons: effect on mobility test outcomes. Drugs Aging 2007; 24 (8): 691-699 (Pubitemid 47294716)
21. Ballard C, Hanney ML, TheodoulouM, et al. The Dementia Antipsychotic Withdrawal Trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009; 8 (2): 151-157
22. Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001; 51 (3): 257-265 (Pubitemid 32396417)
23. Medicare Australia statistics [online]. Available from URL: https://www.medicareaustralia.gov.au [Accessed 2008 Sep 8]
24. Nissen D. editor. Mosby's drug consult. St Louis (MO): Mosby Inc., 2004
25. Duplay D. editor. Physicians' Desk Reference. 58th ed. Montvale (NJ): Thomson PDR, 2004
26. Tallarida RJ. Drug synergism: its detection and applications. J Pharmacol Exp Ther 2001; 298 (3): 865-872 (Pubitemid 32761897)
27. Nishtala PS, McLachlan AJ, Bell JS, et al. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16 (8): 621-632
28. Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003; 17 (11): 825-837 (Pubitemid 37082985)
29. Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316 (7): 363-369
30. Mort JR, Aparasu RR. Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs 2002; 16 (2): 99-109
31. Rochon PA, Normand SL, Gomes T, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008; 168 (10): 1090-1096 (Pubitemid 351749226)
32. Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006; 332 (7539): 455-459 (Pubitemid 43342043)
33. Bottiggi KA, Salazar JC, Yu L, et al. Long-term cognitive impact of anticholinergic medications in older adults. Am J Geriatr Psychiatry 2006; 14 (11): 980-984 (Pubitemid 44706417)
34. Hutt E, Pepper GA, Vojir C, et al. Assessing the appropriateness of pain medication prescribing practices in nursing homes. J Am Geriatr Soc 2006; 54 (2): 231-239
35. Sorensen L, Stokes JA, Purdie DM, et al. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 2004; 58 (6): 648-664 (Pubitemid 39665152)
36. Patel HR, Pruchnicki MC, Hall LE. Assessment for chronic kidney disease service in high-risk patients at community health clinics. Ann Pharmacother 2005; 39 (1): 22-27
37. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30 (3): 205-211 (Pubitemid 32684900)
38. O'Dell KM, Kucukarslan SN. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome. Ann Pharmacother 2005; 39 (9): 1423-1427 (Pubitemid 41197120)
39. Sellors J, Kaczorowski J, Sellors C, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 2003; 169 (1): 17-22 (Pubitemid 36898071)
40. Schmidt IK, Claesson CB, Westerholm B, et al. Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother 1998; 32 (1): 27-32 (Pubitemid 28087229)
41. Department of Health and Ageing, Commonwealth of Australia. A literature review and description of the regulatory framework. 2005 Nov [online]. Available from URL: http://www.health.gov.au/internet/main/publishing.nsf/ Content/ageing-iar-review-framework.htmeageing-iar-reviewframework- 2.htm [Accessed 2008 Nov 28]